135 related articles for article (PubMed ID: 12004443)
1. [Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].
Einecke U
MMW Fortschr Med; 2002 Apr; 144(15):14. PubMed ID: 12004443
[No Abstract] [Full Text] [Related]
2. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
Lewis EJ; Lewis JB
J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
[No Abstract] [Full Text] [Related]
4. Diabetic nephropathy.
Goto A
N Engl J Med; 2002 Sep; 347(12):947-8; author reply 947-8. PubMed ID: 12239270
[No Abstract] [Full Text] [Related]
5. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
Diabetes Metab Syndr; 2012; 6(4):215-7. PubMed ID: 23199543
[TBL] [Abstract][Full Text] [Related]
6. Treating diabetic nephropathy--are there only economic issues?
Mitch WE
N Engl J Med; 2004 Nov; 351(19):1934-6. PubMed ID: 15516698
[No Abstract] [Full Text] [Related]
7. [Therapy of diabetic nephropathy].
Barna I
Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and ACE inhibitors.
Boulton AJ; Gokal R
J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
[No Abstract] [Full Text] [Related]
9. [Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights].
Martinelli L; Ceriello A
Recenti Prog Med; 2003 Mar; 94(3):131-5. PubMed ID: 12677781
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
Rosner MH; Okusa MD
Arch Intern Med; 2003 May; 163(9):1025-9. PubMed ID: 12742799
[TBL] [Abstract][Full Text] [Related]
11. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
12. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Zidek W
MMW Fortschr Med; 2004 Oct; 146(42):51-2. PubMed ID: 15536706
[No Abstract] [Full Text] [Related]
13. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
Blankfield RP
N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11870250
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
16. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
[TBL] [Abstract][Full Text] [Related]
17. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-Il-receptor blockers and nephropathy in patients with type 2 diabetes.
Farquhar D
CMAJ; 2001 Nov; 165(10):1379. PubMed ID: 11760990
[No Abstract] [Full Text] [Related]
20. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
